AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 45 filers reported holding AURA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $49,000 | +4.3% | 5,452 | +41.0% | 0.00% | – |
Q2 2023 | $47,000 | +291.7% | 3,866 | +192.2% | 0.00% | – |
Q1 2023 | $12,000 | -57.1% | 1,323 | -50.7% | 0.00% | – |
Q4 2022 | $28,000 | +600.0% | 2,681 | +1102.2% | 0.00% | – |
Q3 2022 | $4,000 | +300.0% | 223 | +116.5% | 0.00% | – |
Q2 2022 | $1,000 | -87.5% | 103 | -70.1% | 0.00% | – |
Q1 2022 | $8,000 | -57.9% | 345 | -70.2% | 0.00% | – |
Q4 2021 | $19,000 | – | 1,158 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $66,878,000 | 18.12% |
Decheng Capital Management III (Cayman), LLC | 210,000 | $4,620,000 | 1.42% |
Matrix Capital Management Company, LP | 4,112,870 | $90,483,000 | 1.09% |
Rock Springs Capital Management LP | 1,008,114 | $22,179,000 | 0.56% |
Nantahala Capital Management | 301,990 | $6,644,000 | 0.29% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,297,019 | $28,534,000 | 0.05% |
Citadel Advisors | 2,316,653 | $48,263,000 | 0.01% |
Allianz Asset Management GmbH | 55,145 | $1,213,000 | 0.00% |
BARCLAYS PLC | 59,697 | $1,314,000 | 0.00% |
FMR LLC | 494,109 | $10,870,000 | 0.00% |